167 related articles for article (PubMed ID: 33713456)
1. Correlation of anti-γ/ε nicotinic acetylcholine receptor antibody levels with anti-desmoglein 1,3 antibody levels and disease severity in pemphigus vulgaris.
Toosi R; Teymourzadeh A; Mahmoudi H; Balighi K; Daneshpazhooh M
Clin Exp Dermatol; 2021 Oct; 46(7):1230-1235. PubMed ID: 33713456
[TBL] [Abstract][Full Text] [Related]
2. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
Bhatia SM; Streilein RD; Hall RP
PLoS One; 2020; 15(6):e0233957. PubMed ID: 32555697
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
4. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
5. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
6. Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus.
Lakshmi MJD; Jaisankar TJ; Rajappa M; Thappa DM; Chandrashekar L; Divyapriya D; Munisamy M; Revathy G
J Am Acad Dermatol; 2017 May; 76(5):895-902. PubMed ID: 28089115
[TBL] [Abstract][Full Text] [Related]
7. Correlation of conventional and conformational anti-desmoglein antibodies with phenotypes and disease activities in patients with pemphigus vulgaris.
Li Z; Zhang J; Xu H; Jin P; Feng S; Wang B
Acta Derm Venereol; 2015 Apr; 95(4):462-5. PubMed ID: 25178305
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
[TBL] [Abstract][Full Text] [Related]
9. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
10. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
[TBL] [Abstract][Full Text] [Related]
11. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.
Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D
Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pathogenicity of anti-desmoglein antibodies of pemphigus vulgaris patients using human organ culture assay.
Saleh AM; El-Samanoudy SI; Rashed LA; Saleh MA
Arch Dermatol Res; 2020 May; 312(4):289-294. PubMed ID: 31587106
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
Barnadas MA; Rubiales MV; Gich I; Gelpí C
Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
[TBL] [Abstract][Full Text] [Related]
15. Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.
Avgerinou G; Papafragkaki DK; Nasiopoulou A; Markantoni V; Arapaki A; Servitzoglou M; Katsambas A; Stavropoulos PG
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):430-5. PubMed ID: 22221266
[TBL] [Abstract][Full Text] [Related]
16. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
[TBL] [Abstract][Full Text] [Related]
17. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus.
Jerbi A; Hachicha H; Feki S; Abida O; Bahloul E; Sellami K; Bouzid A; Turki H; Masmoudi A; Masmoudi H
Tunis Med; 2021 Octobre; 99(10):992-999. PubMed ID: 35288901
[TBL] [Abstract][Full Text] [Related]
20. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
